Exploiting genomics to mitigate the public health impact of antimicrobial resistance

C Waddington, ME Carey, CJ Boinett, E Higginson… - Genome medicine, 2022 - Springer
Antimicrobial resistance (AMR) is a major global public health threat, which has been largely
driven by the excessive use of antimicrobials. Control measures are urgently needed to slow …

Drug resistance mutations in HIV: new bioinformatics approaches and challenges

L Blassel, A Zhukova, CJ Villabona-Arenas… - Current opinion in …, 2021 - Elsevier
Highlights•Machine learning is increasingly used to predict and understand drug resistance
in HIV.•Phylogenetics helps to track the emergence and spread of HIV drug resistance …

Transmitted drug resistance to integrase-based first-line human immunodeficiency virus antiretroviral regimens in Mediterranean Europe

A de Salazar, L Viñuela, A Fuentes… - Clinical Infectious …, 2023 - academic.oup.com
Background We evaluated the prevalence of transmitted drug resistance (TDR) to integrase
strand-transfer inhibitors (INSTIs) and nucleoside/nucleotide reverse transcriptase inhibitors …

HIV-1 drug resistance detected by next-generation sequencing among ART-naïve individuals: A systematic review and meta-analysis

F Ouyang, D Yuan, W Zhai, S Liu, Y Zhou, H Yang - Viruses, 2024 - mdpi.com
Background: There are an increasing number of articles focused on the prevalence and
clinical impact of pretreatment HIV drug resistance (PDR) detected by Sanger sequencing …

Epidemiology of HIV drug resistance in low-and middle-income countries and WHO global strategy to monitor its emergence

S Bertagnolio, MR Jordan, A Giron… - Current Opinion in HIV …, 2022 - journals.lww.com
Current Opinion in HIV and AIDS Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity …

M Gabrielaite, M Bennedbæk… - PLoS computational …, 2023 - journals.plos.org
Background Infection with human immunodeficiency virus type 1 (HIV) typically results from
transmission of a small and genetically uniform viral population. Following transmission, the …

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing …

A Cozzi‐Lepri, D Dunn, A Tostevin, RL Marvig… - HIV …, 2024 - Wiley Online Library
Objectives The main objective of this analysis was to evaluate the impact of pre‐existing
drug resistance by next‐generation sequencing (NGS) on the risk of treatment failure (TF) of …

Prevalence and evolution of transmitted human immunodeficiency virus drug resistance in Belgium between 2013 and 2019

V Mortier, L Debaisieux, G Dessilly… - Open forum …, 2022 - academic.oup.com
Background To assess the prevalence and evolution of transmitted drug resistance (TDR) in
Belgium, a total of 3708 baseline human immunodeficiency virus (HIV)-1 polymerase …

[HTML][HTML] Next-generation sequencing and drug resistance mutations of HIV-1 subtypes in people living with HIV in Sicily, Italy, 2021–2023

L Pipitò, M Trizzino, C Mascarella, S Cannella… - Journal of Global …, 2025 - Elsevier
Objectives HIV-1 infection continues to be a significant public health concern,
notwithstanding the expanded utilization of antiretroviral treatment (ART), due to the …

[HTML][HTML] Brief report: bictegravir/emtricitabine/tenofovir alafenamide efficacy in participants with preexisting primary integrase inhibitor resistance through 48 weeks of …

ML D'Antoni, K Andreatta, R Acosta… - JAIDS Journal of …, 2022 - journals.lww.com
Background: Preexisting drug resistance limits the utility of HIV antiretroviral therapy. Studies
have demonstrated safety and efficacy of bictegravir/emtricitabine/tenofovir alafenamide …